Search results
Showing: 10 of 1258
New elearning programme explains the dm+d
Health Education England elearning for healthcare (HEE elfh) worked in partnership with the Academic Health Science Networks (AHSN), NHSX, NHS Digital and NHS Business Services Authority (NHSBSA) to create a new elearning programme.
The elearning…
Information security
Last updated 27 February 2026Keeping your personal information secureAs an arm’s length body (ALB) to the Department of Health and Social Care and wider HM Government, we are bound to follow the HMG Security Policy Framework to make…
Registering for eOPS
The eOPS system is available only to those who have registered for an account.It is important that users read the information and requirements before applying to access eOPS.eOPS Account TypesCommissioner AccessThis will give you access to eOPS…
Summary of NHSBSA Board minutes - 16 October 2025
Meeting held at 9:00am in Stella House, Newcastle Upon Tyne. Present: Sue Douthwaite, ChairMichael Brodie, Chief ExecutiveKathy Gillatt, Non-Executive DirectorDavid Leather, Non-Executive DirectorMathew McKie, Non-Executive DirectorRandeep…
Pharmacy First June 2025
This is a news article on behalf of the Department of Health and Social Care
The clinical protocols and patient group directions (PGDs) for the NHS Pharmacy First service were updated in June 2025 to include some changes to the…
Prescription Cost Analysis - England 2019
Correction notice - a column was omitted from the presentation level tables of the latest release
Read our correction notices page for full details. Go to our Office for Statistics Regulation Assessment page to view their assessment of…
Summary of NHSBSA Board minutes - 19 June 2025
Meeting held at 9:00am in Stella House, Newcastle Upon Tyne.
Present:
Sue Douthwaite, Chair
Michael Brodie, Chief Executive
Kathy Gillatt, Non-Executive Director
David Leather, Non-Executive Director
Mathew McKie, Non-Executive…
Prescribing monitoring document (PMD)
Access to PMD for:registered users is through ePACT2public users is through Catalyst - for national PMD reportPMD provides monthly financial information about prescribing costs against budgets. This allows the drugs element of unified…
Rivaroxaban addition to Category A and M from September 2024
The addition of the following products into Category A:
Rivaroxaban 2.5mg tablets
Rivaroxaban 10mg tablets
The addition of the following products into Category M:
Rivaroxaban 15mg tablets
Rivaroxaban 20mg tablets
These additions are…
Drug Reimbursement – Azathioprine 50mg/5ml oral suspension
Since February 2024, a licensed version of Azathioprine 50mg/5ml oral suspension became available. Therefore, for prescriptions dispensed in February and March 2024:
where there is an endorsement for the licensed product, then reimbursement will…